DK0659406T3 - Lægemiddelformulering med reguleret afgivelse - Google Patents

Lægemiddelformulering med reguleret afgivelse

Info

Publication number
DK0659406T3
DK0659406T3 DK94120709T DK94120709T DK0659406T3 DK 0659406 T3 DK0659406 T3 DK 0659406T3 DK 94120709 T DK94120709 T DK 94120709T DK 94120709 T DK94120709 T DK 94120709T DK 0659406 T3 DK0659406 T3 DK 0659406T3
Authority
DK
Denmark
Prior art keywords
inner layer
drug formulation
drug
water
biocompatible material
Prior art date
Application number
DK94120709T
Other languages
English (en)
Inventor
Keiji Fujioka
Kenji Hirasawa
Akihiro Sano
Yosuke Urabe
Takeshi Hirasawa
Masako Kajihara
Shuichi Sugawara
Original Assignee
Dow Corning Asia Ltd
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Asia Ltd, Sumitomo Pharma filed Critical Dow Corning Asia Ltd
Application granted granted Critical
Publication of DK0659406T3 publication Critical patent/DK0659406T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
DK94120709T 1993-12-27 1994-12-27 Lægemiddelformulering med reguleret afgivelse DK0659406T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33146793A JP3720386B2 (ja) 1993-12-27 1993-12-27 薬物放出制御製剤

Publications (1)

Publication Number Publication Date
DK0659406T3 true DK0659406T3 (da) 2000-07-03

Family

ID=18243976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94120709T DK0659406T3 (da) 1993-12-27 1994-12-27 Lægemiddelformulering med reguleret afgivelse

Country Status (15)

Country Link
US (1) US5851547A (da)
EP (1) EP0659406B1 (da)
JP (1) JP3720386B2 (da)
KR (1) KR100349960B1 (da)
CN (1) CN1107497C (da)
AT (1) ATE190836T1 (da)
AU (1) AU686713B2 (da)
CA (1) CA2139058C (da)
DE (1) DE69423582T2 (da)
DK (1) DK0659406T3 (da)
ES (1) ES2146633T3 (da)
GR (1) GR3033248T3 (da)
NZ (1) NZ277548A (da)
PT (1) PT659406E (da)
WO (1) WO1995017881A1 (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056734A (en) * 1997-02-07 2000-05-02 Sarcos Lc Method for automatic dosing of drugs
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
IL133105A (en) 1997-06-04 2004-09-27 Debio Rech Pharma Sa Implants for controlled release of pharmaceutically active principles and method for making same
TW586944B (en) * 1998-05-29 2004-05-11 Sumitomo Pharma Controlled release agent having a multi-layer structure
US20020087184A1 (en) * 1998-06-18 2002-07-04 Eder Joseph C. Water-soluble coating for bioactive devices
TWI246928B (en) * 1998-09-10 2006-01-11 Sumitomo Pharma Long time drug-sustained release preparation
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
AU3957400A (en) * 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
CN1391490A (zh) * 1999-08-25 2003-01-15 乔治敦大学 包括空心“种子”、优选金属“种子”的治疗用递送系统及其应用
TW524696B (en) 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations
US6375972B1 (en) * 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
JP2002003406A (ja) * 2000-06-21 2002-01-09 Sankyo Co Ltd 脳血管攣縮予防製剤
WO2002005744A1 (en) * 2000-07-14 2002-01-24 Novo Nordisk A/S Method of moulding a pharmaceutical composition in a packaging material
CA2451187C (en) 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
CN1638747A (zh) * 2002-01-24 2005-07-13 斯玛特药物系统公司 持续释放药物组合物
JP4026745B2 (ja) * 2002-03-26 2007-12-26 財団法人大阪産業振興機構 医療用システムおよびその製造方法
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
PT2561860T (pt) 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
SI1610791T1 (sl) 2003-03-31 2011-05-31 Titan Pharmaceuticals Inc Implantibilna polimerna naprava za zadržano sproščanje dopaminskega agonista
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
US20050031668A1 (en) * 2003-05-30 2005-02-10 Patel Rajesh A. Implantable polymeric device for sustained release of nalmefene
PT1638535E (pt) * 2003-06-26 2007-11-08 Mediolanum Pharmaceuticals Ltd Implantes subcutâneos com libertação inicial de princípio activo limitada e subsequente sua libertação extensiva com variação linear
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
ATE508750T1 (de) 2005-12-12 2011-05-15 Women And Infants Hospital Of Rhode Island Derivate von vitamin d und ihre verwendung in der therapie
US20080081064A1 (en) * 2006-09-28 2008-04-03 Surmodics, Inc. Implantable Medical Device with Apertures for Delivery of Bioactive Agents
WO2008070557A2 (en) * 2006-12-01 2008-06-12 Women & Infants Hospital Organometallic complexes as therapeutic agents
US20080153906A1 (en) * 2006-12-13 2008-06-26 Celly Chander S Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System
WO2008091946A2 (en) 2007-01-24 2008-07-31 Women & Infants Hospital N-amino tetrahydrothiazine derivatives, method of manufacture and use
AR066166A1 (es) * 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
WO2010091234A2 (en) 2009-02-06 2010-08-12 The General Hospital Corporation Methods of treating vascular lesions
EP2246063A1 (en) 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. Sustained release formulations comprising GnRH analogues
EP2437684B1 (en) 2009-06-03 2022-06-15 ForSight Vision5, Inc. Anterior segment drug delivery
US9040062B2 (en) 2010-08-06 2015-05-26 Sumitomo Dainippon Pharma Co., Ltd. Preparation for treatment of spinal cord injury
CA2807225A1 (en) 2010-08-06 2012-02-09 Miho Maeda Pharmaceutical preparation for controlling water-soluble drug release
CA2848397C (en) 2011-09-14 2022-04-26 Forsight Vision5, Inc. Ocular insert apparatus and methods
WO2014066775A1 (en) 2012-10-26 2014-05-01 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
WO2015086489A1 (en) 2013-12-11 2015-06-18 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
JP6359390B2 (ja) * 2014-09-05 2018-07-18 テルモ株式会社 インプラントデバイスおよびインプラントデバイス植え込み具
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
WO2018067882A1 (en) 2016-10-05 2018-04-12 Titan Pharmaceuticals, Inc. Implantable devices for drug delivery with reduced burst release
AU2019294615A1 (en) * 2018-06-25 2021-02-11 ReacX Pharmaceuticals, Inc. Implants for release of lipophilic or amphiphilic pharmaceutical substances
KR102442807B1 (ko) * 2021-01-29 2022-09-15 주식회사 티온랩테라퓨틱스 초기 방출 제어된 데포 조성물 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
FR2240817B1 (da) * 1973-08-16 1981-04-17 Roland Offsetmaschf
JPS5513381Y2 (da) * 1974-02-21 1980-03-26
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
JPS58781B2 (ja) * 1978-07-17 1983-01-07 風早 清志 畳表の自動裁断装置
US4191741A (en) * 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
DE3022800A1 (de) * 1980-06-19 1982-01-07 Bayer Ag, 5090 Leverkusen Verfahren zur temperaturregelung exothermer reaktionen durch ueberhitzung von wasserdampf
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
JPH0761959B2 (ja) * 1985-10-11 1995-07-05 住友製薬株式会社 シリコンエラストマ−系徐放性製剤
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
DE3769707D1 (de) * 1986-06-17 1991-06-06 Recordati Chem Pharm Therapeutisches system mit geregelter wirkstoffabgabe.
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
DK606288D0 (da) * 1988-03-24 1988-10-31 Bukh Meditec Praeparat
EP0406315B1 (en) * 1988-03-24 1992-11-11 Bukh Meditec A/S Controlled release composition
JPH02142738A (ja) * 1988-11-24 1990-05-31 Nippon Zeon Co Ltd 徐放性医薬製剤およびその製法
JP3118009B2 (ja) * 1991-04-16 2000-12-18 住友製薬株式会社 多層構造を有するコラーゲンおよび／またはゼラチン製剤の製造方法
JPH06321803A (ja) * 1993-05-17 1994-11-22 Kirin Brewery Co Ltd 水溶性ペプチドホルモンの徐放性製剤

Also Published As

Publication number Publication date
ATE190836T1 (de) 2000-04-15
KR100349960B1 (ko) 2003-03-06
CA2139058C (en) 2004-11-16
NZ277548A (en) 1997-05-26
CA2139058A1 (en) 1995-06-28
EP0659406B1 (en) 2000-03-22
AU686713B2 (en) 1998-02-12
GR3033248T3 (en) 2000-09-29
DE69423582T2 (de) 2000-09-07
CN1107497C (zh) 2003-05-07
EP0659406A2 (en) 1995-06-28
AU1280995A (en) 1995-07-17
JPH07187994A (ja) 1995-07-25
JP3720386B2 (ja) 2005-11-24
EP0659406A3 (en) 1995-11-15
DE69423582D1 (de) 2000-04-27
US5851547A (en) 1998-12-22
ES2146633T3 (es) 2000-08-16
PT659406E (pt) 2000-06-30
WO1995017881A1 (en) 1995-07-06
CN1142763A (zh) 1997-02-12

Similar Documents

Publication Publication Date Title
EP0659406A3 (en) Controlled release drug formulation.
ATE195252T1 (de) Wirkstoffabgabevorrichtung mit gesteuerter freigabe
BR9607752A (pt) Formulação farmacêutica de microcápsula de liberação controlada, processo para sua preparação, e, processo de uso das microcápsulas
GEP20022833B (en) New Controlled Release Bead, Method of Producing the Same and Multiple Unit Formulation Comprising It
BR9503346A (pt) Grânulo entérico de duloxetina
MX9700850A (es) Formulaciones y metodos para proporcionar anestesia local prolongada.
DK1112739T3 (da) Langtidsafgivende depot-præparat
ES491307A0 (es) Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal
NO942396L (no) Preparat med vedvarende frigiving av anti-endotelin substans
FI891865A7 (fi) Atselastiinia sisältäviä lääkkeitä, joista vaikuttava aine vapautuu säädellysti
EP0262893A3 (en) Ocular insert
DE3264400D1 (en) Oxazole derivatives, their preparation and use
DK0540813T3 (da) Acetazolamid-præparat med vedvarende afgift af aktivt stof
MX9205982A (es) Agente para la preparacion de fibras, degradable biologicamente.
DK0659341T3 (da) Fast insecticidt præparat
AU633600B2 (en) Compositions
BRPI9607752B8 (pt) formulação farmacêutica de microcápsula de liberação controlada.
FR2757665B1 (fr) Dispositif autonome, notamment dispositif medical implantable actif, et son programmateur externe, a ajustement dynamique de la puissance d'emission
UA43800A (uk) Спосіб лікування перфоративної виразки дванадцятипалої кишки